Table 4.
CC16 Levels and Clinical Outcomes in 23 Patients With ALI or ARDS
| CC16 Levels, ng/mL |
||
|---|---|---|
| Outcomes | Edema Fluid | Plasma |
| Survivors (n = 10) | 1,810 (176–4,861) | 20 (10–38) |
| Nonsurvivors (n = 13) | 2,119 (360–3,759) | 22 (7–50) |
| p Value | 0.44 | 0.99 |
| ≥ 7 d unassisted ventilation (n = 12) | 1,762 (276–2,966) | 22 (10–42) |
| < 7 d unassisted ventilation (n = 11) | 2,772 (164–4,711) | 22 (7–49) |
| p Value | 0.76 | 0.83 |
| < 7 ICU d (n = 10) | 2,118 (164–3,249) | 28 (16–51) |
| ≥ 7 ICU d (n = 13) | 1,902 (702–4,757) | 20 (8–23) |
| p Value | 0.34 | 0.28 |
*Values are given as the median (IQR), unless otherwise indicated.